{
  "id" : "seer_primary_tumor_88917",
  "algorithm" : "eod_public",
  "version" : "2.1",
  "name" : "EOD Primary Tumor",
  "title" : "EOD Primary Tumor",
  "notes" : "**Note 1:** If both eyes are involved, code the information for the most extensively involved eye in this field. \n\n**Note 2:** This schema has extension codes that are defined as “CLINICAL assessment only” or “PATHOLOGICAL assessment only”  \n* CLINICAL assessment only codes (100, 125, 150, 200, 225, 325, 375, 425, 475, 525, 600, 650, 700) are used when there is a clinical work up only, including physical exam, imaging and biopsy (see **Note 3** for exception)\n* PATHOLOGICAL assessment only codes (175, 250, 275, 350, 400, 450, 500, 750) are used when there is a surgical resection of the primary site (enucleation)(see **Note 3** for exception)\n* Remaining codes (no designation of CLINICAL or PATHOLOGICAL only assessment) can be used based on clinical and/or pathological information\n\n**Note 3:** Pathological staging information from an enucleation always takes precedence over clinical staging, except in cases with neoadjuvant treatment where clinical disease is as extensive as or more extensive than disease at surgery",
  "footnotes" : "(1) Fritz AG, Ries LAG (eds). **SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998)**, National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998\n\n(2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). **SEER Summary Staging Manual-2000: Codes and Coding Instructions**, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001.\n\n(3) Collaborative Stage Work Group of the American Joint Committee on Cancer. **Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05**. American Joint Committee on Cancer (Chicago, IL)\n\n(4) Gress, D.M., Edge, S.B., Gershenwald, J.E., et al. **Principles of Cancer Staging**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017\n\n(5) Mallipatna, A.C., Finger, P.T., et al. **Retinoblastoma**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017",
  "last_modified" : "2021-04-08T19:00:44.598Z",
  "definition" : [ {
    "key" : "eod_primary_tumor",
    "name" : "Code",
    "type" : "INPUT"
  }, {
    "key" : "description",
    "name" : "Description",
    "type" : "DESCRIPTION"
  }, {
    "key" : "eod_2018_t",
    "name" : "EOD 2018 T",
    "type" : "ENDPOINT"
  }, {
    "key" : "ss2018_t",
    "name" : "SS2018 T",
    "type" : "ENDPOINT"
  } ],
  "rows" : [ [ "100", "CLINICAL assessment only\n\nIntraretinal tumor(s) with subretinal fluid\n- Equal to but not greater than 3 millimeter (mm)\n- AND Location not closer than 1.5 mm to optic disk or fovea", "VALUE:T1a", "VALUE:L" ], [ "125", "CLINICAL assessment only\n\nIntraretinal tumor(s) with subretinal fluid\n- Greater than 3 millimeter (mm)\n- AND Location closer than 1.5 mm from disc or fovea", "VALUE:T1b", "VALUE:L" ], [ "150", "CLINICAL assessment only\n\nIntraretinal tumor(s) with subretinal fluid ≤5 mm from the base of any tumor\n\nTumor confined to retina, NOS\nLocalized, NOS", "VALUE:T1", "VALUE:L" ], [ "175", "PATHOLOGICAL assessment only\n\nIntraocular tumor(s) WITHOUT any \n- Local invasion\n- Focal choroidal invasion \n- Pre- or intralaminar involvement of the optic nerve head\n\nTumor confined to retina, NOS\nLocalized, NOS", "VALUE:T1", "VALUE:L" ], [ "200", "CLINICAL assessment only\n\nIntraocular tumor(s) WITH\n- Subretinal fluid greater than 5 mm [0.5 cm] from base of tumor\n- WITH or WITHOUT retinal detachment", "VALUE:T2a", "VALUE:L" ], [ "225", "CLINICAL assessment only\n\nIntraocular tumor(s) WITH\n- Vitreous seeding and/or subretinal seeding\n- WITH or WITHOUT retinal detachment", "VALUE:T2b", "VALUE:L" ], [ "250", "PATHOLOGICAL assessment only\n\nIntraocular tumor(s) WITH local invasion\n- Concomitant focal choroidal invasion \n- AND pre- or intralaminar involvement of optic nerve head", "VALUE:T2a", "VALUE:L" ], [ "275", "PATHOLOGICAL assessment only\n\nIntraocular tumor(s) WITH local invasion\nStromal invasion iris\n- AND/OR trabecular meshwork \n- AND/OR Schlemm's canal", "VALUE:T2b", "VALUE:L" ], [ "300", "Intraocular tumor(s) WITH local invasion, NOS\nIntraocular tumor(s) with retinal detachment, vitreous seeding, or subretinal seeding, NOS", "VALUE:T2", "VALUE:L" ], [ "325", "CLINICAL assessment only\n\nAdvanced intraocular tumor(s) WITH\n- Phthisis or pre-phthisis bulbi", "VALUE:T3a", "VALUE:L" ], [ "350", "PATHOLOGICAL assessment only\n\nIntraocular tumor(s) WITH significant local invasion\n- Massive choroidal invasion (greater than 3 mm [0.3 cm] in largest diameter)\n- OR multiple foci or focal choroidal involvement (greater than 3 mm)\n- OR full-thickness choroidal involvement", "VALUE:T3a", "VALUE:L" ], [ "375", "CLINICAL assessment only\n\nAdvanced intraocular tumor(s) WITH invasion of\n- Anterior chamber\n- Choroid\n- Ciliary body\n- Iris\n- Lens\n- Pars plana\n- Zonules", "VALUE:T3b", "VALUE:L" ], [ "400", "PATHOLOGICAL assessment only\n\nIntraocular tumor(s) WITH significant local invasion\n- Retrolaminar invasion of optic nerve head\n- NOT involving transected end of optic nerve", "VALUE:T3b", "VALUE:L" ], [ "425", "CLINICAL assessment only\n\nAdvanced intraocular tumor(s) WITH\n- Raised intraocular pressure with neovascularization \n- AND/OR buphthalmos", "VALUE:T3c", "VALUE:L" ], [ "450", "PATHOLOGICAL assessment only\n\nIntraocular tumor(s) WITH significant local invasion\n- Any partial-thickness involvement of sclera within inner two thirds", "VALUE:T3c", "VALUE:L" ], [ "475", "CLINICAL assessment only\n\nAdvanced intraocular tumor(s) WITH\n- Hyphema AND/OR massive vitreous hemorrhage", "VALUE:T3d", "VALUE:L" ], [ "500", "PATHOLOGICAL assessment only\n\nAdvanced intraocular tumor(s) WITH\n- Full-thickness invasion into outer third of sclera \n- AND/OR invasion into or around emissary channels", "VALUE:T3d", "VALUE:L" ], [ "525", "CLINICAL assessment only\n\nAdvanced intraocular tumor(s) WITH\n- Aseptic orbital cellulitis", "VALUE:T3e", "VALUE:L" ], [ "550", "Advanced intraocular tumor(s) WITH significant local invasion", "VALUE:T3", "VALUE:L" ], [ "600", "CLINICAL assessment only\n\nExtraocular tumor(s) involving orbit\n- Radiologic evidence of retrobulbar optic nerve involvement \n- OR thickening of optic nerve and/or orbital tissues", "VALUE:T4a", "VALUE:RE" ], [ "650", "CLINICAL assessment only\n\nExtraocular tumor(s) involving orbit, including optic nerve\n- WITH proptosis AND/OR an orbital mass", "VALUE:T4b", "VALUE:RE" ], [ "700", "CLINICAL assessment only\n\nExtraocular tumor(s) involving orbit, including optic nerve, NOS", "VALUE:T4", "VALUE:RE" ], [ "750", "PATHOLOGICAL assessment only\n\nEvidence of extraocular tumor\n- Tumor at transected end of optic nerve\n- Tumor in the meningeal spaces around optic nerve\n\nFull-thickness invasion of sclera WITH invasion of \n- Adjacent adipose tissue\n- Bone\n- Conjunctiva\n- Episclera \n- Extraocular muscle\n- Eyelids", "VALUE:T4", "VALUE:RE" ], [ "800", "No evidence of primary tumor", "VALUE:T0", "VALUE:U" ], [ "999", "Unknown; extension not stated\nPrimary tumor cannot be assessed\nNot documented in medical record\n\nDeath Certificate Only", "VALUE:TX", "VALUE:U" ] ]
}